Ailsa Craig: “pharma used to have a worse reputation than tobacco”

We’re all very grateful to the healthcare industry for the amazing work it has done to create vaccines and treatments to help fight the pandemic. But what is the investment outlook now for the companies in the biotech sector?In this interview, Ailsa Craig of the International Biotechnology Trust (IBT) shares what types of companies she looks to own, where she sees the value in the biotech industry currently and how the development of coronavirus treatments has impacted holdings in the fund. Ailsa was named co-lead manager of the trust last month, alongside Marek Poszepczynski, following the announcement of Dr Carl Harald Janson’s departure, manager of the trust since 2013.  Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.